"Nuclear Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
| Descriptor ID |
D009687
|
| MeSH Number(s) |
D12.776.660
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nuclear Proteins".
Below are MeSH descriptors whose meaning is more specific than "Nuclear Proteins".
This graph shows the total number of publications written about "Nuclear Proteins" by people in this website by year, and whether "Nuclear Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 4 | 0 | 4 |
| 1994 | 2 | 2 | 4 |
| 1995 | 2 | 1 | 3 |
| 1996 | 15 | 3 | 18 |
| 1997 | 12 | 3 | 15 |
| 1998 | 7 | 6 | 13 |
| 1999 | 9 | 10 | 19 |
| 2000 | 21 | 7 | 28 |
| 2001 | 11 | 9 | 20 |
| 2002 | 14 | 8 | 22 |
| 2003 | 18 | 8 | 26 |
| 2004 | 12 | 12 | 24 |
| 2005 | 11 | 10 | 21 |
| 2006 | 13 | 5 | 18 |
| 2007 | 11 | 4 | 15 |
| 2008 | 5 | 7 | 12 |
| 2009 | 20 | 18 | 38 |
| 2010 | 14 | 7 | 21 |
| 2011 | 13 | 13 | 26 |
| 2012 | 23 | 8 | 31 |
| 2013 | 18 | 9 | 27 |
| 2014 | 15 | 9 | 24 |
| 2015 | 13 | 6 | 19 |
| 2016 | 12 | 6 | 18 |
| 2017 | 13 | 9 | 22 |
| 2018 | 12 | 9 | 21 |
| 2019 | 9 | 3 | 12 |
| 2020 | 4 | 4 | 8 |
| 2021 | 4 | 7 | 11 |
| 2022 | 1 | 6 | 7 |
| 2023 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nuclear Proteins" by people in Profiles.
-
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC. Cancer Discov. 2023 Jul 07; 13(7):1556-1571.
-
The nuclear envelope and metastasis. Oncotarget. 2023 04 14; 14:317-320.
-
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leuk Lymphoma. 2023 05; 64(5):972-980.
-
NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leuk Res. 2022 Dec; 123:106965.
-
NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions. Am J Surg Pathol. 2022 12 01; 46(12):1706-1715.
-
Report of the First International Symposium on NUT Carcinoma. Clin Cancer Res. 2022 06 13; 28(12):2493-2505.
-
The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. Cell Mol Life Sci. 2022 May 09; 79(6):285.
-
BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia. Mol Neurodegener. 2022 05 07; 17(1):33.
-
Therapeutic Targeting of EZH2 and BET BRD4 in Pediatric Rhabdoid Tumors. Mol Cancer Ther. 2022 05 04; 21(5):715-726.
-
Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. Nat Cell Biol. 2022 02; 24(2):168-180.